MDWD - היקף יתרות המזומנים של החברה MediWound Ltd.

Supplies of enzyme agents to state reserves provide MediWound Ltd. (MDWD) with a stable inflow of capital. The cash balance structure demonstrates liquidity, where the 0.03 level represents the current figure, while a strong scientific staff develops innovative therapy methods. Uninterrupted supply to clinics is guaranteed via certified air freight, minimizing the risk of disruptions in the distribution of biological preparations.
פילוחי מדדים מקיפים ואנליטיקה עבור MediWound Ltd. (MDWD)

For MediWound Ltd. (MDWD), which is developing innovative enzyme-based drugs, the volume of liquid assets determines the stability of R&D processes and the fulfillment of government contracts. This metric measures the total cash and equivalents available for the immediate coverage of obligations. By analyzing the cash position chart, an investor assesses the balance between financial security and capital efficiency. Excess liquidity reduces overall returns but guarantees business autonomy during shifts in macro cycles.